Lipancrea Lipazy (Amylase, Lipase, Protease)

The three enzymes act together in the gastrointestinal tract: amylase breaks down complex carbohydrates into simple sugars, lipase hydrolyzes dietary fats into fatty acids and monoglycerides, and protease cleaves proteins into amino acids and peptides. By providing these enzymes externally, Lipancrea Lipazy compensates for the body's reduced pancreatic output, facilitating normal digestion.

The specific dose of Lipancrea Lipazy is individualized. A qualified prescriber determines the amount based on the patient’s age, weight, severity of enzyme deficiency, and dietary fat content. Dosage adjustments are made according to clinical response and nutritional goals, and the prescribing information provides guidance for titration.

Safety data for Lipancrea Lipazy in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers should evaluate each case and discuss potential risks and benefits with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After receiving the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Lipancrea Lipazy contains a balanced mix of amylase, lipase and protease, similar to other pancreatic enzyme replacements. Compared with products that contain only lipase, Lipancrea Lipazy offers broader digestive support by also addressing carbohydrate and protein digestion. Clinical efficacy and tolerability are comparable, but selection often depends on individual patient response, dosing convenience and cost considerations.

Lipancrea Lipazy should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and avoid exposure to extreme temperatures. Do not refrigerate or freeze unless specifically instructed by the manufacturer.

Lipancrea Lipazy is taken orally, usually with meals or snacks that contain fat, protein and carbohydrates. The tablets or capsules are swallowed whole with a sufficient amount of water. The timing of administration is important to ensure the enzymes are present in the gastrointestinal tract when food is being digested.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, fibrosing colonopathy (a form of intestinal fibrosis), and acute pancreatitis. Patients should seek immediate medical attention if they experience symptoms like difficulty breathing, swelling of the face or throat, persistent abdominal pain, or unusual changes in stool consistency.

Lipancrea Lipazy is contraindicated in individuals with known hypersensitivity to any of its enzyme components or excipients. Patients with a history of severe allergic reactions to pancreatic enzyme preparations should avoid its use. Additionally, those with active gastrointestinal obstruction or severe inflammatory bowel disease should be evaluated carefully before initiating therapy.